van Zyl, Louis <br/><br/>
Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.  [electronic resource] 

 -  Clinical therapeutics  Nov 2002 
 - 1840-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/s0149-2918(02)80083-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--adverse effects<br/>Ceftizoxime--adverse effects<br/>Cephalosporins--adverse effects<br/>Child<br/>Community-Acquired Infections--drug therapy<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Pneumonia, Pneumococcal--drug therapy<br/>Prospective Studies<br/>South Africa<br/>Streptococcus pneumoniae--drug effects<br/>Treatment Outcome<br/>United States<br/>Cefpodoxime Proxetil